产品
编 号:F070562
分子式:C27H25N5O2
分子量:451.52
产品类型
规格
价格
是否有货
结构图
联系客服
产品详情
生物活性:
DMH2 is a potent BMP receptor antagonist. DMH2 downregulates the expression of Id1 and Id3 proteins, and inhibits the proliferation and induces cell death of lung cancer cell lines.

体内研究:
DMH2 (0-2 mg/kg, IP, twice daily, for 2 days prior to PH (partial hepatectomy) and for 2 days after PH) increases hepatocyte proliferation from 13.7% to 26.9% at 2 mg/kg.Animal Model:C57BL/6 mice (7-8 weeks, male)
Dosage:0.5, 1, 2 mg/kg
Administration:IP, twice daily, for 2 days prior to PH and for 2 days after PH (partial hepatectomy)
Result:Increased hepatocyte proliferation from 13.7% to 26.9% at 2 mg/kg.

体外研究:
DMH2 decreases expression of Id1 and Id3 and causes growth suppression of three lung cancer cell lines with K-Ras mutation (A549, H157, H727) and three without a K-Ras mutation (H1299, H865, U1752).The combination of DMH2 and PP2 causes significantly greater reduction in Id1 promoter activity and growth inhibition than either agent alone in the A549 cells.
产品资料